Finanzen von Pharvaris NV (PHVS)PHVSPharvaris NV

Evaluating the bottom line, Pharvaris N.V. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -73.02%, provide a clear picture of how effectively PHVS converts its operational activities into shareholder value.

In the context of the broader market, PHVS competes directly with industry leaders such as VERA and PGEN. With a market capitalization of $2.43B, it holds a significant position in the sector. When comparing efficiency, PHVS's gross margin of N/A stands against VERA's N/A and PGEN's 94.90%. Such benchmarking helps identify whether Pharvaris N.V. is trading at a premium or discount relative to its financial performance.

Pharvaris has been experiencing significant losses, with a net income of -39,200,673 EUR reported in Q1 2026. The company has a forward P/E ratio of 0, indicating no expected earnings in the near future.